POSC34 Comparative Efficacy and Safety of Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Multiple Myeloma Using a Matching-Adjusted Indirect Comparison
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.180
https://www.valueinhealthjournal.com/article/S1098-3015(21)01975-6/fulltext
Title :
POSC34 Comparative Efficacy and Safety of Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Multiple Myeloma Using a Matching-Adjusted Indirect Comparison
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01975-6&doi=10.1016/j.jval.2021.11.180
First page :
Section Title :
Open access? :
No
Section Order :
10947